Reduced genomic 5-methylcytosine content in human colonic neoplasia

Andrew P Feinberg, C. W. Gehrke, K. C. Kuo, M. Ehrlich

Research output: Contribution to journalArticle

Abstract

DNA methylation appears to play an important role in both physiological and experimentally modified gene expression, and alterations in DNA methylation have been described in animal tumor models and in transformed cells and tumor cell lines. However, there have been comparatively few reports on DNA methylation in primary human malignancies, and these reports are somewhat contradictory. While individual genes have shown hypomethylation in colon cancer and premalignant adenomas as well as in lung cancer, other genes have shown increased methylation, and absolute measures of 5-methylcytosine content have shown decreases in malignancies but not in premalignant adenomas. We have used a sensitive quantitative measurement of 5-methylcytosine content by high performance liquid chromatography revealing an unequivocal hypomethylation of tumor DNA. An average of 8 and 10% reduction in genomic 5-methylcytosine content was seen in apparently all colon adenomas and adenocarcinomas, respectively, and there was no significant difference between benign and malignant tumors. This is a substantial quantitative alteration and suggests a pervasive abnormality in the control of DNA methylation. Surprisingly, three patients with the highest 5-methylcytosine content in their normal colon appear to have a germline predisposition to cancer (Lynch syndrome).

Original languageEnglish (US)
Pages (from-to)1159-1161
Number of pages3
JournalCancer Research
Volume48
Issue number5
StatePublished - 1988
Externally publishedYes

Fingerprint

5-Methylcytosine
DNA Methylation
Adenoma
Neoplasms
Colon
Hereditary Nonpolyposis Colorectal Neoplasms
Neoplasm Genes
Tumor Cell Line
Colonic Neoplasms
Methylation
Lung Neoplasms
Adenocarcinoma
Animal Models
High Pressure Liquid Chromatography
Gene Expression
DNA
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988). Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Research, 48(5), 1159-1161.

Reduced genomic 5-methylcytosine content in human colonic neoplasia. / Feinberg, Andrew P; Gehrke, C. W.; Kuo, K. C.; Ehrlich, M.

In: Cancer Research, Vol. 48, No. 5, 1988, p. 1159-1161.

Research output: Contribution to journalArticle

Feinberg, AP, Gehrke, CW, Kuo, KC & Ehrlich, M 1988, 'Reduced genomic 5-methylcytosine content in human colonic neoplasia', Cancer Research, vol. 48, no. 5, pp. 1159-1161.
Feinberg, Andrew P ; Gehrke, C. W. ; Kuo, K. C. ; Ehrlich, M. / Reduced genomic 5-methylcytosine content in human colonic neoplasia. In: Cancer Research. 1988 ; Vol. 48, No. 5. pp. 1159-1161.
@article{d72fc6f5138a4a878a5e70d16c0347ec,
title = "Reduced genomic 5-methylcytosine content in human colonic neoplasia",
abstract = "DNA methylation appears to play an important role in both physiological and experimentally modified gene expression, and alterations in DNA methylation have been described in animal tumor models and in transformed cells and tumor cell lines. However, there have been comparatively few reports on DNA methylation in primary human malignancies, and these reports are somewhat contradictory. While individual genes have shown hypomethylation in colon cancer and premalignant adenomas as well as in lung cancer, other genes have shown increased methylation, and absolute measures of 5-methylcytosine content have shown decreases in malignancies but not in premalignant adenomas. We have used a sensitive quantitative measurement of 5-methylcytosine content by high performance liquid chromatography revealing an unequivocal hypomethylation of tumor DNA. An average of 8 and 10{\%} reduction in genomic 5-methylcytosine content was seen in apparently all colon adenomas and adenocarcinomas, respectively, and there was no significant difference between benign and malignant tumors. This is a substantial quantitative alteration and suggests a pervasive abnormality in the control of DNA methylation. Surprisingly, three patients with the highest 5-methylcytosine content in their normal colon appear to have a germline predisposition to cancer (Lynch syndrome).",
author = "Feinberg, {Andrew P} and Gehrke, {C. W.} and Kuo, {K. C.} and M. Ehrlich",
year = "1988",
language = "English (US)",
volume = "48",
pages = "1159--1161",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Reduced genomic 5-methylcytosine content in human colonic neoplasia

AU - Feinberg, Andrew P

AU - Gehrke, C. W.

AU - Kuo, K. C.

AU - Ehrlich, M.

PY - 1988

Y1 - 1988

N2 - DNA methylation appears to play an important role in both physiological and experimentally modified gene expression, and alterations in DNA methylation have been described in animal tumor models and in transformed cells and tumor cell lines. However, there have been comparatively few reports on DNA methylation in primary human malignancies, and these reports are somewhat contradictory. While individual genes have shown hypomethylation in colon cancer and premalignant adenomas as well as in lung cancer, other genes have shown increased methylation, and absolute measures of 5-methylcytosine content have shown decreases in malignancies but not in premalignant adenomas. We have used a sensitive quantitative measurement of 5-methylcytosine content by high performance liquid chromatography revealing an unequivocal hypomethylation of tumor DNA. An average of 8 and 10% reduction in genomic 5-methylcytosine content was seen in apparently all colon adenomas and adenocarcinomas, respectively, and there was no significant difference between benign and malignant tumors. This is a substantial quantitative alteration and suggests a pervasive abnormality in the control of DNA methylation. Surprisingly, three patients with the highest 5-methylcytosine content in their normal colon appear to have a germline predisposition to cancer (Lynch syndrome).

AB - DNA methylation appears to play an important role in both physiological and experimentally modified gene expression, and alterations in DNA methylation have been described in animal tumor models and in transformed cells and tumor cell lines. However, there have been comparatively few reports on DNA methylation in primary human malignancies, and these reports are somewhat contradictory. While individual genes have shown hypomethylation in colon cancer and premalignant adenomas as well as in lung cancer, other genes have shown increased methylation, and absolute measures of 5-methylcytosine content have shown decreases in malignancies but not in premalignant adenomas. We have used a sensitive quantitative measurement of 5-methylcytosine content by high performance liquid chromatography revealing an unequivocal hypomethylation of tumor DNA. An average of 8 and 10% reduction in genomic 5-methylcytosine content was seen in apparently all colon adenomas and adenocarcinomas, respectively, and there was no significant difference between benign and malignant tumors. This is a substantial quantitative alteration and suggests a pervasive abnormality in the control of DNA methylation. Surprisingly, three patients with the highest 5-methylcytosine content in their normal colon appear to have a germline predisposition to cancer (Lynch syndrome).

UR - http://www.scopus.com/inward/record.url?scp=0023848637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023848637&partnerID=8YFLogxK

M3 - Article

C2 - 3342396

AN - SCOPUS:0023848637

VL - 48

SP - 1159

EP - 1161

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -